Magnet removal and reinsertion in a cochlear implant recipient undergoing brain MRI.

ORL J Otorhinolaryngol Relat Spec

Department of Otolaryngology and Head and Neck Surgery, Sheba Medical Center Affiliated to Sackler School of Medicine, Tel Aviv University, Tel Hashomer, Israel. migirovl @ gmail.com

Published: February 2014

Background: Recent advances in cochlear implants (CIs) and in magnetic resonance imaging (MRI) techniques have led to increasing numbers of implanted patients who have undergone brain MRIs for various reasons. This paper first describes the surgical procedure for removing the magnet before an MRI and its subsequent reinsertion immediately afterwards in a CI recipient.

Method: After the administration of local anesthesia, the magnet was removed by a surgical incision made along the posterior margin of the receiver-stimulator. The flap was elevated and the capsule over the implant was incised. The magnet was removed, maintained under sterile conditions and reinserted immediately after the completion of the 1.5-Tesla MRI.

Results: The patient was able to wear her device immediately after surgery. Large CI-associated artifacts were observed on the MRIs irrespective of sequences. The function of the device was not altered by either the MRI or the surgical procedure.

Conclusion: The proposed surgical incision that follows the posterior margins of the receiver-stimulator allows the wearing of the device immediately after the surgical procedure. An MRI has limited diagnostic value for lesions located on the implanted side due to unavoidable artifacts, even after the magnet has been removed.

Download full-text PDF

Source
http://dx.doi.org/10.1159/000346239DOI Listing

Publication Analysis

Top Keywords

magnet removed
12
surgical procedure
8
surgical incision
8
incision posterior
8
magnet
5
mri
5
surgical
5
magnet removal
4
removal reinsertion
4
reinsertion cochlear
4

Similar Publications

Enzyme-linked immunosorbent spot analysis is frequently used to investigate immune responsiveness during clinical trials. However, ELISpot classically utilizes peripheral blood mononuclear cell isolates from whole blood, requiring relatively high blood draw volumes and removing both granulocytes and bound drug. Here, we describe a novel protocol whereby CD45 cells are magnetically isolated from human whole blood and co-incubated with serum isolated from the same subject.

View Article and Find Full Text PDF

Purpose: To analyze the clinical data of five patients involving intravesical magnetic beads, summarizing diagnostic and therapeutic experiences.

Methods: From January 2018 to November 2023, five pediatric patients were treated for intravesical magnetic beads at Shenzhen Children's Hospital. We retrospectively reviewed and analyzed the records of these patients, including demographic characteristics, clinical symptoms, imaging studies, and treatment methods.

View Article and Find Full Text PDF

Integration of ratiometric, ultrafast, sensitive detection as well as rapid and efficient removal of tetracycline based on a novel Zn (II) functionalized magnetic covalent organic framework.

Anal Chim Acta

March 2025

State Key Laboratory of Chemo/Biosensing and Chemometrics, College of Chemistry and Chemical Engineering, Hunan University, Changsha, 410082, PR China. Electronic address:

Background: Based on the low volatility and refractory nature of Tetracycline (TC), excessive use leads to its continuous accumulation in water environments, posing serious risks to the ecological environment and human health. Although a very limited number of nanomaterials capable of simultaneously detecting and removing TC have been fabricated, they generally exist issues associated with a single detection signal ("on" or "off") or low adsorption rates with low adsorption capacities. As a result, it is crucial to develop a reliable technique to achieve ratiometric detection as well as rapid and efficient removal of TC.

View Article and Find Full Text PDF

Measuring XNA polymerase fidelity in a hydrogel particle format.

Nucleic Acids Res

January 2025

Department of Pharmaceutical Sciences, University of California, Irvine, CA 92697-3958, United States.

Growth in the development of engineered polymerases for synthetic biology has led to renewed interest in assays that can measure the fidelity of polymerases that are capable of synthesizing artificial genetic polymers (XNAs). Conventional approaches require purifying the XNA intermediate of a replication cycle (DNA → XNA → DNA) by denaturing polyacrylamide gel electrophoresis, which is a slow, costly, and inefficient process that requires a large-scale transcription reaction and careful extraction of the XNA strand from the gel slice. In an effort to streamline the assay, we developed a purification-free approach in which the XNA transcription and reverse transcription steps occur inside the matrix of a hydrogel-coated magnetic particle.

View Article and Find Full Text PDF

This study focuses on developing biochar-based adsorbents with high adsorption capacity and rapid adsorption rates for removing boron from aqueous solutions. Hydroxy-enriched biochar composites (BC (carboxylated biochar), BC-PDA (polydopamine loaded biochar), MBC-PDA (polydopamine loaded magnetic biochar), BC-AlOOH (AlOOH loaded biochar), and BC-ZnCl (biochar modified by ZnCl)) were synthesized specifically for boron adsorption to utilize the superior adsorption capacity of biochar. All adsorbents were synthesized using straightforward experimental techniques from date palm cellulosic fibers as promising lignocellulose feedstock and subjected to various characterization methods.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!